Literature DB >> 33593073

miR-33 Silencing Reprograms the Immune Cell Landscape in Atherosclerotic Plaques.

Milessa Silva Afonso1,2, Monika Sharma1,2, Martin Schlegel1,2,3, Coen van Solingen1,2, Graeme J Koelwyn1,2, Lianne C Shanley1,2, Lauren Beckett1, Daniel Peled1,2, Karishma Rahman1,2, Chiara Giannarelli4, Huilin Li5, Emily J Brown1,2, Alireza Khodadadi-Jamayran6, Edward A Fisher1,2, Kathryn J Moore1,2.   

Abstract

[Figure: see text].

Entities:  

Keywords:  adaptive immunity; atherosclerosis; inflammation; macrophages; microRNA

Mesh：

Substances：

Year:  2021        PMID： 33593073      PMCID： PMC8049965          DOI： 10.1161/CIRCRESAHA.120.317914

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


  71 in total

1.  microRNA-33 Regulates Macrophage Autophagy in Atherosclerosis.

Authors:  Mireille Ouimet; Hasini Ediriweera; Milessa Silva Afonso; Bhama Ramkhelawon; Ragunath Singaravelu; Xianghai Liao; Rachel C Bandler; Karishma Rahman; Edward A Fisher; Katey J Rayner; John P Pezacki; Ira Tabas; Kathryn J Moore
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-04-20       Impact factor: 8.311

2.  E-Selectin Inhibition Mitigates Splenic HSC Activation and Myelopoiesis in Hypercholesterolemic Mice With Myocardial Infarction.

Authors:  Partha Dutta; Friedrich Felix Hoyer; Yuan Sun; Yoshiko Iwamoto; Benoit Tricot; Ralph Weissleder; John L Magnani; Filip K Swirski; Matthias Nahrendorf
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07-28       Impact factor: 8.311

3.  Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets.

Authors:  Ryan D Michalek; Valerie A Gerriets; Sarah R Jacobs; Andrew N Macintyre; Nancie J MacIver; Emily F Mason; Sarah A Sullivan; Amanda G Nichols; Jeffrey C Rathmell
Journal:  J Immunol       Date:  2011-02-11       Impact factor: 5.422

Review 4.  Bridging the gap for lipid lowering therapy: plaque regression, coronary computed tomographic angiography, and imaging-guided personalized medicine.

Authors:  Alan C Kwan; Konstantinos N Aronis; Veit Sandfort; Roger S Blumenthal; David A Bluemke
Journal:  Expert Rev Cardiovasc Ther       Date:  2017-07-06

5.  Rapid regression of atherosclerosis with MTP inhibitor treatment.

Authors:  Bernd Hewing; Saj Parathath; Christina K Mai; M Isabel Fiel; Liang Guo; Edward A Fisher
Journal:  Atherosclerosis       Date:  2013-01-01       Impact factor: 5.162

6.  miR33 inhibition overcomes deleterious effects of diabetes mellitus on atherosclerosis plaque regression in mice.

Authors:  Emilie Distel; Tessa J Barrett; Kellie Chung; Natasha M Girgis; Saj Parathath; Christine C Essau; Andrew J Murphy; Kathryn J Moore; Edward A Fisher
Journal:  Circ Res       Date:  2014-09-08       Impact factor: 17.367

Review 7.  Interferons as Essential Modulators of Atherosclerosis.

Authors:  Marieke C S Boshuizen; Menno P J de Winther
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-05-07       Impact factor: 8.311

8.  Regression of atherosclerosis is characterized by broad changes in the plaque macrophage transcriptome.

Authors:  Jonathan E Feig; Yuliya Vengrenyuk; Vladimir Reiser; Chaowei Wu; Alexander Statnikov; Constantin F Aliferis; Michael J Garabedian; Edward A Fisher; Oscar Puig
Journal:  PLoS One       Date:  2012-06-27       Impact factor: 3.240

9.  Single-cell immune landscape of human atherosclerotic plaques.

Authors:  Dawn M Fernandez; Adeeb H Rahman; Nicolas F Fernandez; Aleksey Chudnovskiy; El-Ad David Amir; Letizia Amadori; Nayaab S Khan; Christine K Wong; Roza Shamailova; Christopher A Hill; Zichen Wang; Romain Remark; Jennifer R Li; Christian Pina; Christopher Faries; Ahmed J Awad; Noah Moss; Johan L M Bjorkegren; Seunghee Kim-Schulze; Sacha Gnjatic; Avi Ma'ayan; J Mocco; Peter Faries; Miriam Merad; Chiara Giannarelli
Journal:  Nat Med       Date:  2019-10-07       Impact factor: 53.440

10.  Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution.

Authors:  Jonathan D Proto; Amanda C Doran; Galina Gusarova; Arif Yurdagul; Erdi Sozen; Manikandan Subramanian; Mohammad N Islam; Christina C Rymond; Jasper Du; Jaime Hook; George Kuriakose; Jahar Bhattacharya; Ira Tabas
Journal:  Immunity       Date:  2018-10-02       Impact factor: 43.474
View more
  9 in total

1.  Inhibition of microRNA-33b specifically ameliorates abdominal aortic aneurysm formation via suppression of inflammatory pathways.

Authors:  Tomohiro Yamasaki; Takahiro Horie; Satoshi Koyama; Tetsushi Nakao; Osamu Baba; Masahiro Kimura; Naoya Sowa; Kazuhisa Sakamoto; Kazuhiro Yamazaki; Satoshi Obika; Yuuya Kasahara; Jun Kotera; Kozo Oka; Ryo Fujita; Takashi Sasaki; Akihiro Takemiya; Koji Hasegawa; Kenji Minatoya; Takeshi Kimura; Koh Ono
Journal:  Sci Rep       Date:  2022-07-14       Impact factor: 4.996

Review 2.  Decoding microRNA drivers in atherosclerosis.

Authors:  Tanwi Vartak; Soundharya Kumaresan; Eoin Brennan
Journal:  Biosci Rep       Date:  2022-07-29       Impact factor: 3.976

Review 3.  Targeting the cytoskeleton and extracellular matrix in cardiovascular disease drug discovery.

Authors:  Bohdan B Khomtchouk; Yoon Seo Lee; Maha L Khan; Patrick Sun; Deniel Mero; Michael H Davidson
Journal:  Expert Opin Drug Discov       Date:  2022-03-08       Impact factor: 7.050

4.  Reducing Endogenous Labile Zn May Help to Reduce Smooth Muscle Cell Injury around Vascular Stents.

Authors:  Zheng Zeng; Yinhong Xie; Li Li; Huanran Wang; Jianying Tan; Xia Li; Qihao Bian; Yu Zhang; Tao Liu; Yajun Weng; Junying Chen
Journal:  Int J Mol Sci       Date:  2022-05-05       Impact factor: 6.208

Review 5.  How Single-Cell Technologies Have Provided New Insights Into Atherosclerosis.

Authors:  Natalia Eberhardt; Chiara Giannarelli
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-02-03       Impact factor: 8.311

Review 6.  The Endothelium as a Hub for Cellular Communication in Atherogenesis: Is There Directionality to the Message?

Authors:  Kathryn L Howe; Myron Cybulsky; Jason E Fish
Journal:  Front Cardiovasc Med       Date:  2022-04-15

Review 7.  Foam Cells in Atherosclerosis: Novel Insights Into Its Origins, Consequences, and Molecular Mechanisms.

Authors:  Yuzhou Gui; Hongchao Zheng; Richard Y Cao
Journal:  Front Cardiovasc Med       Date:  2022-04-13

Review 8.  Development of hydrogen sulfide donors for anti-atherosclerosis therapeutics research: Challenges and future priorities.

Authors:  Ye-Wei Yang; Nian-Hua Deng; Kai-Jiang Tian; Lu-Shan Liu; Zuo Wang; Dang-Heng Wei; Hui-Ting Liu; Zhi-Sheng Jiang
Journal:  Front Cardiovasc Med       Date:  2022-08-12

9.  The microRNA-204-5p inhibits APJ signalling and confers resistance to cardiac hypertrophy and dysfunction.

Authors:  Ravinder Reddy Gaddam; Young-Rae Kim; Julia S Jacobs; Jin-Young Yoon; Qiuxia Li; Angela Cai; Hamsitha Shankaiahgari; Barry London; Kaikobad Irani; Ajit Vikram
Journal:  Clin Transl Med       Date:  2022-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.